Immunovant, Inc. · NASDAQ:IMVT
Van Tuyl Christopher sold 17,824 Immunovant, Inc. shares (Form 4)
Traded Jun 26, 2026 · Filed Jun 26, 2026
On Jun 26, 2026, Van Tuyl Christopher (Chief Legal Officer) sold 17,824 Immunovant, Inc. shares at an average US$38.31 for US$683K, leaving 180,597 shares. Filed Jun 26, 2026 (Form 4).
- Sold
- 17,824 shares
- Price
- US$38.31 average (US$38.19 to US$38.96)
- Value
- US$683K
- Holding after
- 180,597 shares
- Trading plan
- No
- Role
- Chief Legal Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 26, 2026 | Common Stock | Option exercise | 17,824 | US$15.20 | 198,421 | Direct |
| Jun 26, 2026 | Common Stock | Sale | 14,982 | US$38.19 | 183,439 | Direct |
| Jun 26, 2026 | Common Stock | Sale | 2,842 | US$38.96 | 180,597 | Direct |
Source
Related
- Immunovant, Inc.
- Van Tuyl Christopher
- Immunovant, Inc. shareholders
- Form 4 · Van Tuyl Christopher · Oct 9, 2026
- Form 4 · Van Tuyl Christopher · Sep 25, 2026
- Form 4 · Van Tuyl Christopher · Jul 10, 2026
- Form 4 · Van Tuyl Christopher · Jun 22, 2026
- Form 4 · Van Tuyl Christopher · Apr 10, 2026
- Form 4 · Gloria Melanie · Oct 9, 2026
- Form 4 · Stout Jay S · Oct 9, 2026
- Form 4 · Venker Eric · Oct 5, 2026
- Form 4 · Pande Atul · Aug 28, 2026
- Form 4 · Gloria Melanie · Aug 21, 2026